Dr.Debarati Mukherjee

Dr.Subhankar Home, Dr. DEBJANI MUKHOPADHYAY, Dr.Arnav Mitra

Abstract

Dexamethasone implant is now being used in various cases raging from refractory and naive DME and RVOs as well as post Operative CME. STUDY:Retrospective study of 30 eyes with macular edema(CMT> 300microns) without having glaucoma or being a glaucoma suspect or history of steroid responder and not recieved any injection in last 3 months was done. 10 eyes having post-op CME, 12 havingDME, 4 having RVO and 4 having intermediate uveitis with CME were given the implant.Vision improvement at 3 months(.795 to .335) and cetral macular thickness(458.5 to 274 microns) was statistically significant. 20% had > 5 mm IOP rise.Visual gain was maintained in most upto 6 months.10% needed another injection due to increased CMT or visual drop and 3 patients needed adjuvant focal laser.cataract progression noted in 2/10 eyes.conclusion: use of dexamethasone implant is safe and effective for treating macular edema and IOP rise can be controlled by topical and oral medications.